Section 2799-B. Legislative findings

The legislature hereby recognizes that
  reflex  sympathetic  dystrophy  syndrome  (RSDS)  is  a debilitating and
  progressively chronic condition characterized by  severe  burning  pain,
  pathological  changes  in  bone  and  skin,  excessive  sweating, tissue
  swelling, and extreme sensitivity to touch. More specifically,  RSDS  is
  thought  to  be  a nerve disorder that generally occurs at the site of a
  minor or major trauma injury, but may also  occur  without  an  apparent
  injury  to  the  afflicted person. While the causes of RSDS are unknown,
  the syndrome is thought to be  the  result  of  damaged  nerves  of  the
  sympathetic   nervous   system.  The  disorder  is  unique  in  that  it
  simultaneously affects the nerves, skin,  muscles,  blood  vessels,  and
  bones.
    The  legislature further finds that RSDS is often misdiagnosed because
  this condition is either unknown or is poorly understood. The  prognosis
  for  patients  suffering  from  RSDS  is  generally much better when the
  condition is identified and treated as early as possible, ideally within
  three months of identifying the first symptoms. If treatment is delayed,
  the disorder can quickly spread to the entire limb, and changes in  bone
  and  muscle  may  become  irreversible,  resulting  in limited mobility,
  atrophy of the muscles, and  eventual  disability  and  unemployment  of
  patients.
    Since  a  delay in diagnosis or treatment for this syndrome can result
  in severe physical and physiological problems, and early recognition and
  prompt treatment of RSDS provides the greatest opportunity for recovery,
  the legislature hereby declares it to be in the  best  interest  of  the
  public  to  establish  a  program  to  educate,  via  written materials,
  brochures, and the internet, both individuals and medical  professionals
  regarding   this   debilitative  disease  and  to  promote  research  to
  accurately identify, diagnose, and treat this disease.